Skip to main content
    S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.26
    -0.06 (-19.96%)

    Market Cap: $7.63M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(6/13)
    Avg Surprise
    -7.39%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.29
    Range$-0.38 - $-0.21
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.32+8.8%
    60d ago$-0.38+21.7%
    30d ago$-0.38+21.7%
    7d ago$-0.38+21.7%
    Current$-0.29
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.13
    Range$-0.39 - $0.14
    2 analysts
    Revenue Consensus
    $50000
    Range$0 - $100000
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.13---
    Sep 26EST
    		-$-0.29---
    Jun 26
    Reported Aug 14
    		$-0.41$-0.33-24.24%Miss+26.8%
    Mar 26
    Reported May 14
    		$-0.14N/A+61.11%Beat+90.1%
    Dec 25
    Reported Mar 27
    		$-0.53$-0.47-11.98%Miss+20.9%
    Sep 25
    Reported Nov 13
    		$-0.69$-0.57-21.05%Miss+89.1%
    Jun 25
    Reported Aug 7
    		$-0.56$-0.55-1.82%Miss+77.1%
    Mar 25
    Reported May 6
    		$-1.41$-0.56-151.79%Miss-432.1%
    Dec 24
    Reported Mar 20
    		$-0.67N/A+78.59%Beat-59.9%
    Sep 24
    Reported Nov 14
    		$-6.31N/AN/ABeat-156.4%
    Jun 24
    Reported Aug 13
    		$-2.45N/AN/ABeat+41.7%
    Mar 24
    Reported May 9
    		$-0.27$0.00N/ABeat+93.7%
    Dec 23
    Reported Mar 21
    		$-0.42$-0.23-82.22%Miss+0.2%
    Sep 23
    Reported Nov 13
    		$-2.46$-4.28+42.52%Beat+35.3%
    Jun 23
    Reported Aug 11
    		$-4.20$-4.64+9.48%Beat-643.4%
    Mar 23
    Reported May 9
    		$-4.20$-3.90-7.69%Miss-10400.0%
    Dec 22
    Reported Mar 22
    		$-0.42$-0.44+4.55%Beat-281.8%
    Sep 22
    Reported Nov 10
    		$-3.80$-4.15+8.43%Beat-37900.0%
    Jun 22
    Reported Aug 9
    		$-0.56N/AN/ABeat-5550.0%
    Mar 22
    Reported May 16
    		$-0.04N/AN/ABeat-
    Dec 21
    Reported Mar 7
    		$-0.11N/AN/ABeat-
    Sep 21
    Reported Nov 10
    		$-0.01N/AN/ABeat-
    Jun 21
    Reported Jul 2
    		$-0.01N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.14EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-79371.00%
    ROE-466.50%ROIC-6697.39%
    Financial Health
    Debt/Equity-1.17xInterest CoverageN/A
    Current Ratio0.83xQuick Ratio0.83x
    Trading Statistics
    Beta2.22Avg Volume1.11M
    52-Week High$2.4852-Week Low$0.24

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.32
    SMA 20$0.32
    SMA 50$0.35
    SMA 200$0.78
    EMA 10$0.31
    EMA 20$0.32
    EMA 50$0.39
    EMA 200$0.84

    MACD

    Line: -0.02Signal: -0.02Hist: -0.00

    ADX

    ADX: 19.2+DI: 14.3-DI: 24.4

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down100.0
    PSAR$0.36

    Bollinger Bands

    Upper Band$0.36
    Lower Band$0.28
    %B Position2318%(Upper)
    Band Width-0.36

    RSI (14-Day)

    Neutral
    30.5

    Momentum Oscillators

    Stoch %K16.6
    Stoch %D24.7
    Williams %R-97.5
    ROC (10d)-17.1%
    Momentum-0.05
    CCI (20d)-355.6
    MFI (14d)58.7

    Volatility Measures

    ATR (14d)$0.03(12.4%)
    StdDev (20d)0.02
    Hist Vol93.1%(High)

    Volume Flow

    VWAP$0.27
    OBV-80.2M
    AD Line-83.7M
    CMF (20d)-0.103

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.3x(Low)
    VWMA (20d)$0.33

    Pivot Points

    R3$0.34
    R2$0.33
    R1$0.32
    Pivot Point$0.32
    S1$0.31
    S2$0.30
    S3$0.30

    Advanced Oscillators

    TSI-18.23
    Ultimate Osc40.4
    KST-73.85

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17,000$16,000$22,000$0$0$0$5.86M$0$0$0$333,000$338,000
    Cost of Revenue$0$0$893,000$0$0$0$1.46M$0$0$0$1.47M$0
    Gross Profit$17,000$16,000$22,000$0$0$0$-1,459,000$0$0$0$-1,141,000$338,000
    Operating Expenses$14.51M$4.63M$18.66M$16.95M$16.80M$16.40M$16.17M$15.21M$13.36M$16.30M$18.70M$44.21M
    R&D$7.77M$5.28M$7.76M$10.52M$10.03M$9.28M$7.77M$8.65M$9.15M$8.78M$9.12M$9.09M
    SG&A$6.74M$6.23M$5.85M$6.43M$6.77M$7.12M$8.08M$6.56M$4.21M$7.52M$9.30M$9.43M
    Operating Income$-14,489,000$-4,616,000$-18,636,000$-16,948,000$-16,798,000$-16,397,000$-16,167,000$-15,215,000$-13,356,000$-16,301,000$-18,699,000$-43,876,000
    Interest Income$55,000$101,000$97,000$166,000$270,000$394,000$231,000$150,000$236,000$331,000$426,000$583,000
    Interest Expense$0$0$0$1.18M$0$0$0$13.65M$0$0$0$0
    Income Before Tax$-12,750,000$-4,235,000$-14,658,000$-18,126,000$-14,733,000$-13,912,000$-563,000$-28,866,000$-11,203,000$-12,111,000$-18,689,000$-36,615,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-12,750,000$-4,221,000$-14,467,000$-18,126,000$-14,733,000$-14,112,000$-610,000$-28,866,000$-11,203,000$-12,111,000$-18,716,000$-14,923,000
    EBITDA$-12,138,000$-3,648,000$-13,862,000$-17,388,000$-14,089,000$-13,380,000$143,000$-28,070,000$-10,468,000$-11,458,000$-17,641,000$-35,500,000
    EBIT$-12,805,000$-4,336,000$-14,755,000$-18,292,000$-15,003,000$-14,306,000$-794,000$-29,016,000$-11,439,000$-12,442,000$-19,115,000$-37,198,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SNTI

    News

    Senti Biosciences Adjourns Merger Vote, Seeking Additional Stockholder Support

    Senti Biosciences has adjourned its 2026 Annual Meeting without conducting business to gather more stockholder support for its pending Merger Agreement Proposal. This delay casts uncertainty on the scheduled...

    The Clinical Trial Vanguard•10/14/26•Somewhat-Bearish

    Form 4 Senti Biosciences Holdings Inc For: 24 September By Investing.com

    This article reports that a Form 4 filing for Senti Biosciences Holdings Inc. was submitted for September 24th. The filing indicates insider trading activity for the company. The article provides the company's stock...

    Investing.com India•9/25/26•Neutral

    No cash at closing for Senti Biosciences (NASDAQ: SNTI) shareholders; future payments hinge on milestones.

    Senti Biosciences' merger will not provide immediate cash to shareholders at closing; instead, shareholders will receive Contingent Value Rights (CVRs) tied to the achievement of specific milestones for the SENTI-202...

    Stock Titan•9/25/26•Somewhat-Bearish

    Senti Biosciences Holdings, Inc. SEC Filing (Sep 25, 2026)

    Senti Biosciences Holdings, Inc. (NASDAQ: SNTI) announced an SEC filing regarding a Notice of Effectiveness for an S-3 registration statement. The filing, accepted by SEC EDGAR on September 25, 2026...

    Stock Titan•9/25/26•Neutral

    Senti Biosciences registers resale of 2.55 crore shares from notes

    Senti Biosciences Holdings, Inc. has filed a prospectus to register the resale of up to 25,555,024 common shares by selling securityholders. These shares originate from senior secured convertible notes issued to two...

    scanx.trade•9/24/26•Somewhat-Bearish

    SNTI Valuation and Fair Value

    P/E
    -0.1x
    P/B
    -2.3x
    See GNG's fair value

    SNTI Profitability: Margins, ROIC and FCF

    Operating margin
    -79371.0%
    Net margin
    0.0%
    ROIC
    -6697.4%
    ROE
    -466.5%
    FCF margin
    -69183.6%

    SNTI Competitors

    CompanyTicker
    Tenon Medical IncTNON
    Aprea Therapeutics IncAPRE
    Collplant Biotechnologies LtdCLGN
    Soligenix Inc.SNGX
    CNS Pharmaceuticals IncCNSP
    XWELL Inc.XWEL
    OSR Holdings IncOSRH
    InMed Pharmaceuticals IncINM

    Sector: Healthcare

    SNTI Bull Case vs Bear Case

    Bear case

    • SNTI beat EPS estimates in 25.0% of its last 8 reported quarters.
    • SNTI's quarterly revenue changed -100.0% year over year.

    SNTI Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -10.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.29
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About SNTI

    Does SNTI pay dividends?

    Senti Biosciences Inc (SNTI) does not currently pay a regular dividend.

    What is SNTI's market cap?

    Senti Biosciences Inc (SNTI) has a market capitalization of $7.63M with a current stock price of $0.26.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In